Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
06/10/2009 | 15:00 | PR Newswire (US) | Isolagen, Inc. Reorganizes as Fibrocell Science, Inc. | AMEX:ILE | |
16/06/2009 | 23:52 | PR Newswire (US) | Isolagen, Inc. Announces Filing of Voluntary Petition Under Chapter 11 of the Bankruptcy Code | AMEX:ILE | |
08/05/2009 | 15:00 | PR Newswire (US) | Food and Drug Administration Accepts Isolagen's Biologics License Application for Full Review | AMEX:ILE | |
06/05/2009 | 21:18 | Edgar (US Regulatory) | Current report filing (8-K) | AMEX:ILE | Isolagen |
06/05/2009 | 21:14 | PR Newswire (US) | Isolagen Receives Bridge Financing to Allow it to Seek Debtor-in-Possession Financing in Connection With a Possible Filing Under | AMEX:ILE | |
06/05/2009 | 00:55 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | AMEX:ILE | Isolagen |
30/04/2009 | 23:16 | Edgar (US Regulatory) | Amended Annual Report (10-K/A) | AMEX:ILE | Isolagen |
15/04/2009 | 15:38 | Edgar (US Regulatory) | Annual Report (10-K) | AMEX:ILE | Isolagen |
31/03/2009 | 23:15 | Edgar (US Regulatory) | Notification that Annual Report will be submitted late (NT 10-K) | AMEX:ILE | Isolagen |
20/03/2009 | 22:00 | PR Newswire (US) | Isolagen, Inc. Receives Notification Letter from Amex | AMEX:ILE | Isolagen |
09/03/2009 | 14:00 | PR Newswire (US) | Isolagen, Inc. Submits Biologics License Application for the Treatment of Wrinkles to the U.S. Food and Drug Administration | AMEX:ILE | Isolagen |
05/03/2009 | 15:25 | PR Newswire (US) | Isolagen, Inc. Reports Positive Top-line Results from Phase II/III Study of Isolagen Therapy(TM) to Treat Moderate to Severe Acn | AMEX:ILE | Isolagen |
17/02/2009 | 19:47 | Edgar (US Regulatory) | Amended Statement of Ownership (SC 13G/A) | AMEX:ILE | Isolagen |
06/11/2008 | 23:27 | Edgar (US Regulatory) | Quarterly Report (10-Q) | AMEX:ILE | Isolagen |
23/10/2008 | 03:58 | PR Newswire (US) | Isolagen, Inc. Provides Analysis of Data from Pivotal Phase III Studies of Isolagen Therapy(TM) in Wrinkles | AMEX:ILE | Isolagen |
21/10/2008 | 14:30 | PR Newswire (US) | Isolagen Inc. Completes Injections of Isolagen Therapy(TM) in Phase II/III Acne Scar Study | AMEX:ILE | Isolagen |
20/10/2008 | 14:30 | PR Newswire (US) | Isolagen to Host Investor Conference Call to Present an Analysis of the Data from Phase III Wrinkle Studies | AMEX:ILE | Isolagen |
06/10/2008 | 23:02 | Edgar (US Regulatory) | Isolagen Inc - Statement of Changes in Beneficial Ownership (4) | AMEX:ILE | Isolagen |
03/10/2008 | 15:00 | PR Newswire (US) | Isolagen to Present at the JMP Securities Healthcare Focus Conference | AMEX:ILE | Isolagen |
25/09/2008 | 23:01 | Edgar (US Regulatory) | Isolagen Inc - Current report filing (8-K) | AMEX:ILE | Isolagen |
25/09/2008 | 15:00 | PR Newswire (US) | Isolagen, Inc. Reaches Agreement in Principle to Settle Its Class Action and Derivative Action Lawsuits | AMEX:ILE | Isolagen |
25/08/2008 | 14:42 | PR Newswire (US) | Isolagen Reports Positive Results from Open Label, Phase II Study of Isolagen Therapy(TM) of the Full Face Regarding the Treatme | AMEX:ILE | Isolagen |
14/08/2008 | 22:07 | PR Newswire (US) | Isolagen, Inc. Receives American Stock Exchange Notice Accepting Its Previously Submitted Plan of Compliance and Canceling the D | AMEX:ILE | Isolagen |
11/08/2008 | 18:04 | Marketwired | *Revised* Analyst Reports for Gammon Gold Inc., Grey Wolf Inc., Isolagen Inc., and SIFCO Industries Inc. | AMEX:ILE | Isolagen |
05/08/2008 | 22:10 | PR Newswire (US) | Isolagen, Inc. Reports Positive Top-line Results from Pivotal Phase III Studies of Isolagen Therapy(TM) in Wrinkles: Studies Mee | AMEX:ILE | Isolagen |
30/07/2008 | 12:04 | Edgar (US Regulatory) | Isolagen Inc - Quarterly Report (10-Q) | AMEX:ILE | Isolagen |
16/07/2008 | 15:00 | PR Newswire (US) | Isolagen, Inc. Receives Notice of Hearing from American Stock Exchange | AMEX:ILE | Isolagen |
02/07/2008 | 16:00 | PR Newswire (US) | Isolagen Completes Pivotal Efficacy Portion of Phase III Studies of Isolagen Therapy(TM) for Wrinkles | AMEX:ILE | Isolagen |
31/05/2008 | 00:00 | PR Newswire (US) | Isolagen, Inc. Reports Receipt of Initiation of Delisting Proceedings Notice from Amex | AMEX:ILE | Isolagen |
29/04/2008 | 15:37 | Edgar (US Regulatory) | Isolagen Inc - Proxy Statement (definitive) (DEF 14A) | AMEX:ILE | Isolagen |